The human carcinoma-derived cell line Calu-6 has previously been demonstrat
ed to endogenously express human renin (hREN) mRNA and to markedly increase
steady-state hREN mRNA levels (100-fold after 24 hours) in response to ana
logues of cAMP and postreceptor activators of adenylyl cyclase such as fors
kolin. However, both transfection analysis using hREN promoter-reporter con
structs and nuclear run-on experiments suggest that transcriptional activit
y alone cannot account for this level of induction. We performed primer ext
ension, reverse transcription-polymerase chain reaction, and 3' rapid ampli
fication of cDNA ends to compare hREN mRNA between unstimulated and forskol
in-stimulated cells. We demonstrate that hREN mRNA is identical under both
conditions with respect to (1) utilization of the appropriate transcription
start site, (2) processing of renin mRNA, and (3) utilization of the prope
r polyadenylation site and length of the poly-A tail. To address the mechan
ism of induction caused by cAMP, we used transcriptional inhibition and mea
sured decay of hREN mRNA before and after forskolin or phorbol ester treatm
ent. Experiments with both actinomycin D and 5,6-dichlororibofuranosylbenzi
midnzole (DRB) showed that forskolin treatment markedly stabilized hREN mRN
A in Calu-6 cells. A 2.3-fold increase in hREN mRNA half-life was also obse
rved after treatment of Calu-6 cells with phorbol ester, Experiments with D
RB demonstrated a similar robust stabilization of hREN mRNA after forskolin
and phorbol ester treatment. These data demonstrate that the induction in
hREN mRNA in response to both cAMP and phorbol ester occurs by a mechanism
involving a posttranscriptional component.